New Blood Test Spots Early Signs of Immunotherapy Effectiveness
1 Articles
1 Articles
New Blood Test Spots Early Signs of Immunotherapy Effectiveness
Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy. Image for illustration purposes Mega Doctor News By Johns Hopkins Medicine Researchers at the Johns Hopkins Kimmel Cancer C…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
